Are inhalers or breathing treatments used for pneumonia or pleurisy? 

Pneumonia and pleurisy are both conditions that affect the respiratory system, but they primarily involve the lung tissue and the surrounding membranes rather than the airways. Because of this, standard inhalers used for conditions like asthma are not typically the primary treatment for these illnesses. However, breathing treatments can play a supportive role in specific circumstances, particularly when a patient has an underlying lung condition or when the infection causes significant mucus buildup or airway narrowing. 

What We’ll Discuss in This Article 

• Why inhalers are not usually the first-line treatment for pneumonia. 

• The role of bronchodilators in patients with pre-existing lung conditions. 

• How nebulisers are used in a hospital setting for severe respiratory distress. 

• The use of saline or mucolytic treatments to help clear lung secretions. 

• Breathing exercises and physiotherapy as non-medicated breathing treatments. 

• When a GP might consider prescribing a temporary inhaler during recovery. 

Inhalers and Pneumonia: The Clinical Connection 

Inhalers are primarily designed to deliver medication directly to the bronchioles (airways) to reduce inflammation or relax the muscles around the air passages. Pneumonia, however, is an infection located deeper in the alveoli (air sacs) where fluid and pus collect. Because the primary issue in pneumonia is the infection of the tissue rather than a tightening of the airways, antibiotics or antivirals are the essential treatments rather than inhalers. 

In a standard case of pneumonia in a healthy individual, an inhaler will not “cure” the infection or speed up the healing of the lung tissue. However, if the infection triggers “reactive airway disease” where the airways become irritated and narrow in response to the inflammation a doctor may prescribe a bronchodilator inhaler, such as salbutamol, to help open the airways and make breathing feel less laboured. You can find more details on managing pneumonia symptoms from the NHS. 

Pleurisy and Breathing Support 

Pleurisy involves inflammation of the pleura, the thin layers covering the lungs, which causes sharp pain during breathing. Unlike asthma or bronchitis, pleurisy does not involve the narrowing of the bronchial tubes. Therefore, inhalers are almost never used to treat pleurisy itself. The primary “breathing treatment” for pleurisy is effective pain relief, which allows the patient to take deep breaths without discomfort. 

If a person with pleurisy stops taking deep breaths because of the pain, the small air sacs in the lungs can collapse. In these cases, a doctor or physiotherapist might recommend “incentive spirometry” or specific deep-breathing techniques. These are mechanical breathing treatments that help keep the lungs expanded and prevent secondary infections like pneumonia from developing while the pleura are inflamed. 

Use of Nebulisers in Hospital Care 

In hospital settings, patients with severe pneumonia may receive breathing treatments via a nebuliser. A nebuliser is a machine that turns liquid medicine into a fine mist that is inhaled through a mask or mouthpiece. This is often used for patients who are too breathless or weak to use a standard handheld inhaler effectively. 

Nebulised treatments for pneumonia may include: 

• Bronchodilators: To open up the airways if there is wheezing. 

• Saline Solution: To help moisten the airways and thin out thick mucus, making it easier to cough up. 

• Mucolytics: Occasionally used to break down the chemical bonds in thick phlegm. 

• Oxygen Therapy: While not a medication in a nebuliser, high-flow oxygen is a critical breathing treatment for those with low blood oxygen levels due to pneumonia. 

Underlying Conditions and “Flare-ups” 

The group most likely to be prescribed inhalers during a bout of pneumonia or pleurisy are those with pre-existing respiratory conditions such as Asthma or Chronic Obstructive Pulmonary Disease (COPD). An infection like pneumonia acts as a significant stressor on the lungs and frequently causes a “flare-up” or exacerbation of these underlying issues. 

For these patients, their usual inhaler regimen may need to be intensified. A doctor might increase the dose of their preventer inhaler (steroid) or advise more frequent use of their reliever inhaler. In this context, the inhaler is treating the underlying airway hyper-reactivity that has been worsened by the pneumonia, rather than treating the pneumonia itself. 

Chest Physiotherapy and Breathing Techniques 

Non-pharmacological breathing treatments are often just as important as medication during recovery. Chest physiotherapy involves specific physical techniques to help dislodge mucus from the lungs. This can include “percussion,” where a therapist or carer gently taps the chest and back, or “active cycle of breathing” techniques that help move secretions into the larger airways where they can be coughed out. 

According to NICE guidance on respiratory infections, encouraging patients to sit upright and move around as soon as they are able is a key part of breathing management. This natural “treatment” helps gravity assist in lung expansion and prevents fluid from pooling in the lower sections of the lungs. 

Conclusion 

Inhalers and nebulisers are not standard treatments for pneumonia or pleurisy unless there is evidence of airway narrowing or a pre-existing condition like asthma. While antibiotics remain the priority for pneumonia and pain relief for pleurisy, breathing treatments such as oxygen therapy, saline nebulisation, and chest physiotherapy are vital supportive tools for more severe cases. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article provides educational information regarding the use of respiratory aids and treatments for pneumonia and pleurisy. It is written and reviewed by Dr. Rebecca Fernandez, a UK-trained physician with extensive experience in internal medicine, intensive care, and emergency medicine. All content is strictly aligned with the clinical standards provided by the NHS and NICE to ensure the highest level of accuracy and safety for UK patients.